Joshua A Vera, PA
Physician Assistant · Bishop
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 15 years
- Graduated 2011
Offices
3 locations · La Laser Center PC A Professional Medical Corporation · 81 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Joshua A Vera’s office to ask if they take your plan before you enroll.
Original Medicare doctor bills
$367,942
Medicare paid this office $367,942 for 697 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 550 | $64,523 | $58 |
| Destruction of precancer skin growth, 15 or more growths | 264 | $48,131 | $119 |
| Destruction of skin growth, 15 or more growths | 285 | $39,215 | $96 |
| Destruction of skin growth, 1-14 growths | 343 | $32,389 | $69 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 58 | $24,047 | $308 |
See all 29 services
| Short return visit (20+ min) | 550 | $64,523 | $58 |
| Destruction of precancer skin growth, 15 or more growths | 264 | $48,131 | $119 |
| Destruction of skin growth, 15 or more growths | 285 | $39,215 | $96 |
| Destruction of skin growth, 1-14 growths | 343 | $32,389 | $69 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 58 | $24,047 | $308 |
| Return visit (30+ min) | 163 | $20,122 | $92 |
| Biopsy of related skin growth, first growth | 274 | $15,393 | $43 |
| Destruction of precancer skin growth, 1 growth | 371 | $14,899 | $28 |
| Destruction of precancer skin growth, 2-14 growths | 326 | $10,283 | $5 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 75 | $10,087 | $93 |
| Biopsy of related skin growth, each additional growth | 153 | $9,634 | $37 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 106 | $9,271 | $61 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 39 | $8,704 | $193 |
| New patient visit (30+ min) | 133 | $8,048 | $61 |
| Complicated repair of wound of trunk, 2.6-7.5 cm | 21 | $6,827 | $284 |
| New patient visit (45+ min) | 43 | $4,420 | $103 |
| Short return visit | 91 | $4,355 | $36 |
| Removal of cancer skin growth of body, arms, or legs, more than 4.0 cm | 11 | $3,990 | $333 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 11 | $3,719 | None |
| Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | 38 | $3,555 | $76 |
| Punch biopsy, first skin growth | 41 | $3,392 | $77 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | 36 | $2,428 | $64 |
| Injection into skin growth, 1-7 growths | 43 | $1,853 | $30 |
| Simple or single drainage of skin abscess | 19 | $1,413 | $74 |
| Punch biopsy, each additional skin growth | 16 | $769 | $43 |
| Biopsy of ear | 17 | $745 | $39 |
| Injection of drug or substance under skin or into muscle | 16 | $562 | $10 |
| Removal of sutures and staples | 13 | $160 | $12 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 47 | $75 | None |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 46 | More than 86% of doctors who do this |
| Removal of skin lesions | 2120 | More than 98% of doctors who do this |
| Removal or shaving of skin growth | 109 | More than 85% of doctors who do this |
| Skin biopsy | 253 | More than 88% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | – | – | – | – | 171 | 2,100 |
| Destruction of precancer skin growth, 1 growth | – | – | – | – | 47 | 525 |
| Destruction of skin growth, 1-14 growths | – | – | – | – | 39 | 471 |
| Destruction of skin growth, 15 or more growths | – | – | – | – | – | 409 |
| Destruction of precancer skin growth, 15 or more growths | – | – | – | – | – | 403 |
| Biopsy of related skin growth, first growth | – | – | – | – | 46 | 356 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
697 Original Medicare patients in 2024. Average age 74 · Under 65 7% · 85 and older 12% · Women 55% · Also on Medicaid 25% · Health risk score 1.05. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 73% · Diabetes 29% · Coronary heart disease 24% · Chronic kidney disease 21% · Atrial fibrillation 18% · Depression 14% · COPD 13% · Heart failure 12% · Cancer 12% · Stroke 6% · Dementia 5%.
The office billed $1,750,619, Medicare allowed $493,895 and paid $367,942; for 7,148 services of 60 kinds; $3,793 of it was for drugs given in the office and $364,148 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 697 | 7,148 | 74 | 1.05 | $1,750,619 | $367,942 |
| 2023 | 273 | 741 | 72 | 1.24 | $289,174 | $37,736 |
| 2022 | 177 | 220 | 70 | 1.25 | $211,358 | $16,860 |
| 2021 | 23 | 27 | 76 | 1.18 | $32,184 | $2,239 |
| 2020 | 59 | 70 | 67 | 1.19 | $50,951 | $4,539 |
| 2019 | 47 | 60 | 69 | 1.37 | $46,954 | $4,681 |
| 2018 | 55 | 66 | 69 | 1.33 | $46,780 | $4,576 |
| 2017 | 191 | 294 | 67 | 1.47 | $163,682 | $16,998 |
| 2016 | 180 | 284 | 67 | 1.25 | $154,568 | $16,939 |
| 2015 | 90 | 121 | 68 | 1.84 | $54,038 | $8,141 |
| 2014 | 32 | 41 | 64 | 1.66 | $13,324 | $2,669 |
| 2013 | 56 | 60 | 59 | 1.44 | $18,883 | $2,000 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Emergency department visit with moderate level of medical decision making | 122 | $10,130 | $80 |
| Short return visit (20+ min) | 79 | $5,247 | $62 |
| Destruction of skin growth, 1-14 growths | 38 | $2,726 | $70 |
| Biopsy of related skin growth, first growth | 45 | $2,325 | $51 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 19 | $1,612 | $73 |
| Destruction of precancer skin growth, 1 growth | 46 | $1,354 | $29 |
| New patient visit (30+ min) | 18 | $1,339 | $74 |
| Biopsy of related skin growth, each additional growth | 23 | $1,290 | $36 |
| Destruction of precancer skin growth, 2-14 growths | 32 | $824 | $5 |
| Short return visit | 13 | $551 | $39 |
| Emergency department visit with low level of medical decision making | 12 | $439 | $37 |
2022: 3 services
| Emergency department visit with moderate level of medical decision making | 64 | $5,978 | $91 |
| Emergency department visit with high level of medical decision making | 38 | $5,238 | $138 |
| Emergency department visit with low level of medical decision making | 70 | $3,760 | $50 |
2021: 1 service
| Emergency department visit with high level of medical decision making | 11 | $1,494 | $136 |
2020: 3 services
| Emergency department visit with high level of medical decision making | 15 | $1,317 | $88 |
| Emergency department visit with low level of medical decision making | 26 | $1,271 | $45 |
| Emergency department visit with moderate level of medical decision making | 16 | $1,196 | $75 |
2019: 3 services
| Emergency department visit with high level of medical decision making | 23 | $2,691 | $117 |
| Emergency department visit with moderate level of medical decision making | 13 | $1,004 | $77 |
| Emergency department visit with low level of medical decision making | 11 | $483 | $44 |
2018: 2 services
| Emergency department visit with moderate level of medical decision making | 22 | $1,717 | $78 |
| Emergency department visit with low level of medical decision making | 23 | $941 | $41 |
2017: 3 services
| Emergency department visit with moderate level of medical decision making | 71 | $5,658 | $78 |
| Emergency department visit with high level of medical decision making | 46 | $5,542 | $115 |
| Emergency department visit with low level of medical decision making | 78 | $3,133 | $40 |
2016: 4 services
| Emergency department visit with high level of medical decision making | 50 | $6,147 | $114 |
| Emergency department visit with moderate level of medical decision making | 61 | $4,956 | $76 |
| Emergency department visit with low level of medical decision making | 76 | $3,473 | $42 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 13 | $71 | $5 |
2015: 4 services
| Emergency department visit with high level of medical decision making | 37 | $4,519 | $122 |
| Emergency department visit with moderate level of medical decision making | 19 | $1,587 | $84 |
| Emergency department visit with low level of medical decision making | 21 | $884 | $42 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 23 | $143 | $6 |
2014: 1 service
| Emergency department visit with low level of medical decision making | 11 | $469 | $43 |
2013: 2 services
| Emergency department visit with low level of medical decision making | 15 | $490 | $33 |
| Short return visit (20+ min) | 12 | $399 | $33 |
Medicaid work
$1,575 in 2024
Medicaid paid $1,575 for 146 billed services this clinician did in 2024, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 108 | $1,190 |
| Return visit (30+ min) | 25 | $271 |
| New patient visit (30+ min) | 13 | $114 |
| 2024 | 146 | 3 | 24 | $1,575 |
| 2023 | 1,897 | 13 | 100 | $131,411 |
| 2022 | 1,434 | 12 | 80 | $84,908 |
| 2021 | 998 | 10 | 63 | $92,878 |
| 2020 | 240 | 5 | 71 | $8,904 |
| 2019 | 139 | 3 | 58 | $4,511 |
| 2018 | 164 | 1 | 36 | $6,104 |
See the largest Medicaid services in earlier years
2023
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | 192 | $71,130 |
| Service | 567 | $20,921 |
| Infectious agent detection by nucleic acid (DNA or RNA); influenza virus, for multiple types or sub-types, includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, first 2 types or sub-types | 187 | $14,332 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia pneumoniae, amplified probe technique | 193 | $9,544 |
| Infectious agent detection by nucleic acid (DNA or RNA); Mycoplasma pneumoniae, amplified probe technique | 193 | $9,262 |
| Service | 299 | $3,570 |
| COMPREHENSIVE METABOLIC PANEL | 64 | $865 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 65 | $646 |
| Radiologic examination, chest; single view | 44 | $428 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 12 | $406 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 54 | $223 |
| Injection, dexamethasone sodium phosphate, 1 mg | 13 | $60 |
2022
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | 105 | $38,195 |
| Service | 555 | $20,691 |
| Infectious agent detection by nucleic acid (DNA or RNA); influenza virus, for multiple types or sub-types, includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, first 2 types or sub-types | 115 | $8,798 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia pneumoniae, amplified probe technique | 89 | $4,374 |
| Infectious agent detection by nucleic acid (DNA or RNA); Mycoplasma pneumoniae, amplified probe technique | 89 | $4,245 |
| Service | 275 | $3,348 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 28 | $1,950 |
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 3-5 targets | 25 | $1,466 |
| Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 30 | $704 |
| COMPREHENSIVE METABOLIC PANEL | 44 | $569 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 45 | $430 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 34 | $138 |
2021
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | 171 | $59,682 |
| Service | 285 | $10,277 |
| Infectious agent detection by nucleic acid (DNA or RNA); influenza virus, for multiple types or sub-types, includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, first 2 types or sub-types | 103 | $7,894 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia pneumoniae, amplified probe technique | 105 | $4,971 |
| Infectious agent detection by nucleic acid (DNA or RNA); Mycoplasma pneumoniae, amplified probe technique | 105 | $4,824 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 39 | $2,700 |
| Service | 128 | $1,425 |
| Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 36 | $845 |
| COMPREHENSIVE METABOLIC PANEL | 13 | $150 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 13 | $110 |
2020
| Service | 176 | $6,749 |
| Infectious agent detection by nucleic acid (DNA or RNA); influenza virus, for multiple types or sub-types, includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, first 2 types or sub-types | 14 | $888 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 16 | $821 |
| Service | 22 | $314 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 12 | $132 |
2019
| Service | 111 | $4,235 |
| Service | 15 | $235 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 13 | $41 |
2018
| Service | 164 | $6,104 |
Drugs they prescribed that Part D paid
$651,388
Pharmacies billed $651,388 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,770) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
1,644 generic and fewer than 11 brand-name prescriptions · $651,388 in drug cost · 243 antibiotic prescriptions to 195 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tremfya | 12 | $154,147 | $12,846 |
| Dupixent | 40 | $136,670 | $3,417 |
| Cosentyx Sensoready (2 Pens) | 19 | $135,506 | $7,132 |
| Ketoconazole | 294 | $7,388 | $25 |
| Clobetasol Propionate | 186 | $6,182 | $33 |
See all 34 drugs
| Tremfya | 12 | $154,147 | $12,846 |
| Dupixent | 40 | $136,670 | $3,417 |
| Cosentyx Sensoready (2 Pens) | 19 | $135,506 | $7,132 |
| Ketoconazole | 294 | $7,388 | $25 |
| Clobetasol Propionate | 186 | $6,182 | $33 |
| Calcipotriene | 22 | $5,658 | $257 |
| Tacrolimus | 35 | $4,517 | $129 |
| Fluorouracil | 57 | $3,731 | $65 |
| Fluocinonide | 55 | $2,835 | $52 |
| Mometasone Furoate | 124 | $2,757 | $22 |
| Azelaic Acid | 24 | $2,538 | $106 |
| Desonide | 56 | $2,457 | $44 |
| Tretinoin | 27 | $2,165 | $80 |
| Gentamicin Sulfate | 45 | $1,729 | $38 |
| Metronidazole | 20 | $1,500 | $75 |
| Doxycycline Hyclate | 109 | $1,430 | $13 |
| Ciclopirox | 30 | $1,185 | $39 |
| Clindamycin Phosphate | 29 | $1,082 | $37 |
| Triamcinolone Acetonide | 65 | $853 | $13 |
| Imiquimod | 24 | $682 | $28 |
| Hydrocortisone | 31 | $535 | $17 |
| Betamethasone Dipropionate | 13 | $435 | $33 |
| Clindamycin | 37 | $423 | $11 |
| Albuterol Sulfate Hfa | 15 | $373 | $25 |
| Spironolactone | 12 | $323 | $27 |
| Fluconazole | 37 | $312 | $8 |
| Cephalexin | 41 | $272 | $7 |
| Ammonium Lactate | 11 | $269 | $24 |
| Amoxicillin-Clavulanate Potass | 14 | $225 | $16 |
| Montelukast | 26 | $168 | $6 |
| Betamethasone Diprop Augmented | 11 | $138 | $13 |
| Prednisone | 36 | $119 | $3 |
| Hydroxyzine | 20 | $80 | $4 |
| Azithromycin | 20 | $67 | $3 |
Year by year
| 2024 | 1,770 | 607 | 0% (0) | None | $651,388 |
| 2023 | 457 | 277 | 3% (13) | 5% | $24,160 |
| 2022 | 324 | 189 | 4% (13) | None | $3,884 |
| 2021 | 176 | 108 | None | None | $3,437 |
| 2020 | 161 | 86 | None | 11% | $3,548 |
| 2019 | 65 | 37 | None | None | $1,453 |
| 2018 | 271 | 149 | 16% (43) | 7% | $3,801 |
| 2017 | 241 | 143 | 24% (58) | None | $4,831 |
| 2016 | 253 | 132 | 25% (62) | None | $31,660 |
| 2015 | 272 | 143 | 19% (51) | 10% | $10,024 |
| 2014 | 242 | 125 | 23% (56) | None | $14,330 |
| 2013 | 164 | 90 | 35% (58) | 7% | $4,449 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Clobetasol Propionate | 13 | $1,350 | $104 |
| Ketoconazole | 29 | $1,242 | $43 |
| Albuterol Sulfate Hfa | 20 | $574 | $29 |
| Clindamycin | 28 | $522 | $19 |
| Amoxicillin-Clavulanate Potass | 21 | $349 | $17 |
| Cephalexin | 40 | $331 | $8 |
| Triamcinolone Acetonide | 18 | $309 | $17 |
| Doxycycline Hyclate | 15 | $270 | $18 |
| Paxlovid (Eua) | 20 | $212 | $11 |
| Baclofen | 21 | $181 | $9 |
| Azithromycin | 28 | $171 | $6 |
| Ibuprofen | 22 | $100 | $5 |
| Naproxen | 15 | $61 | $4 |
| Prednisone | 16 | $44 | $3 |
2022: 10 drugs
| Albuterol Sulfate Hfa | 17 | $684 | $40 |
| Clindamycin | 24 | $358 | $15 |
| Doxycycline Hyclate | 17 | $341 | $20 |
| Baclofen | 27 | $293 | $11 |
| Cephalexin | 32 | $251 | $8 |
| Amoxicillin-Clavulanate Potass | 13 | $184 | $14 |
| Azithromycin | 27 | $179 | $7 |
| Ibuprofen | 31 | $100 | $3 |
| Naproxen | 20 | $76 | $4 |
| Prednisone | 22 | $66 | $3 |
2021: 6 drugs
| Doxycycline Hyclate | 16 | $324 | $20 |
| Clindamycin | 15 | $214 | $14 |
| Baclofen | 15 | $186 | $12 |
| Cephalexin | 21 | $176 | $8 |
| Prednisone | 12 | $60 | $5 |
| Ibuprofen | 12 | $42 | $4 |
2020: 4 drugs
| Albuterol Sulfate Hfa | 15 | $691 | $46 |
| Doxycycline Hyclate | 14 | $390 | $28 |
| Azithromycin | 27 | $175 | $6 |
| Prednisone | 12 | $36 | $3 |
2018: 7 drugs
| Ventolin Hfa | 11 | $604 | $55 |
| Clindamycin | 17 | $245 | $14 |
| Hydrocodone-Acetaminophen | 38 | $204 | $5 |
| Cephalexin | 23 | $173 | $8 |
| Prednisone | 23 | $101 | $4 |
| Naproxen | 18 | $74 | $4 |
| Ibuprofen | 17 | $62 | $4 |
2017: 6 drugs
| Hydrocodone-Acetaminophen | 51 | $224 | $4 |
| Cephalexin | 26 | $181 | $7 |
| Clindamycin | 11 | $144 | $13 |
| Naproxen | 20 | $94 | $5 |
| Ciprofloxacin | 11 | $77 | $7 |
| Prednisone | 12 | $50 | $4 |
2016: 5 drugs
| Hydrocodone-Acetaminophen | 52 | $307 | $6 |
| Clindamycin | 12 | $189 | $16 |
| Cephalexin | 26 | $136 | $5 |
| Naproxen | 21 | $86 | $4 |
| Prednisone | 14 | $59 | $4 |
2015: 6 drugs
| Hydrocodone-Acetaminophen | 35 | $199 | $6 |
| Clindamycin | 12 | $174 | $14 |
| Cephalexin | 21 | $127 | $6 |
| Oxycodone-Acetaminophen | 13 | $83 | $6 |
| Azithromycin | 12 | $80 | $7 |
| Naproxen | 18 | $69 | $4 |
2014: 2 drugs
| Hydrocodone-Acetaminophen | 42 | $272 | $6 |
| Cephalexin | 18 | $138 | $8 |
2013: 3 drugs
| Hydrocodone-Acetaminophen | 30 | $156 | $5 |
| Cephalexin | 12 | $114 | $9 |
| Oxycodone-Acetaminophen | 22 | $100 | $5 |
Money from drug and device companies
$1,814 in 2025
| 2025 | 15 | 101 | None | $1,814 |
| 2024 | 10 | 55 | None | $1,080 |
| 2023 | 2 | 2 | None | $56 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Galderma Laboratories L.P. | Nemluvio | $252 | 12 payments
|
| Genzyme | Dupixent | $225 | 9 payments
|
| Lilly USA | Taltz | $200 | 11 payments
|
| Regeneron Healthcare Solutions | Dupixent | $198 | 6 payments
|
| Janssen Biotech | Tremfya | $194 | 18 payments
|
| Abbvie | Skyrizi | $172 | 12 payments
|
See all 101 published payments
| LEO Pharma | Meals · 2025-12-16 | Adbry | $23 |
| Novartis Pharmaceuticals | Meals · 2025-12-15 | Rhapsido | $35 |
| Incyte | Meals · 2025-12-09 | Opzelura | $22 |
| Janssen Biotech | Meals · 2025-12-08 | Tremfya | $4 |
| Incyte | Meals · 2025-12-01 | Opzelura | $21 |
| Abbvie | Meals · 2025-11-18 | Skyrizi | $33 |
| Novartis Pharmaceuticals | Meals · 2025-11-17 | Rhapsido | $32 |
| Galderma Laboratories L.P. | Meals · 2025-11-11 | Nemluvio | $8 |
| Galderma Laboratories L.P. | Meals · 2025-11-11 | Nemluvio | $3 |
| Genzyme | Meals · 2025-11-05 | Dupixent | $28 |
| Pfizer | Meals · 2025-11-04 | Cibinqo | $25 |
| Janssen Biotech | Meals · 2025-10-28 | Tremfya | $18 |
| Incyte | Meals · 2025-10-22 | Opzelura | $9 |
| Incyte | Meals · 2025-10-22 | Opzelura | $23 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-21 | Sotyktu | $33 |
| Abbvie | Meals · 2025-10-21 | Skyrizi | $8 |
| Incyte | Meals · 2025-10-21 | Opzelura | $12 |
| Galderma Laboratories L.P. | Meals · 2025-10-21 | Nemluvio | $17 |
| Arcutis Biotherapeutics | Meals · 2025-10-15 | Zoryve | $21 |
| Arcutis Biotherapeutics | Meals · 2025-10-13 | Zoryve | $8 |
| Abbvie | Meals · 2025-10-02 | Rinvoq | $24 |
| Galderma Laboratories L.P. | Meals · 2025-10-02 | Nemluvio | $6 |
| Galderma Laboratories L.P. | Meals · 2025-10-01 | Nemluvio | $7 |
| Abbvie | Meals · 2025-09-30 | Skyrizi | $26 |
| Janssen Biotech | Meals · 2025-09-16 | Tremfya | $25 |
| Galderma Laboratories L.P. | Meals · 2025-09-04 | Nemluvio | $16 |
| Incyte | Meals · 2025-09-02 | Opzelura | $20 |
| Ucb | Meals · 2025-08-22 | Bimzelx | $15 |
| Genzyme | Meals · 2025-08-21 | Dupixent | $30 |
| Pfizer | Meals · 2025-08-13 | Cibinqo | $28 |
| Genzyme | Meals · 2025-08-12 | Dupixent | $33 |
| Galderma Laboratories L.P. | Meals · 2025-08-07 | Nemluvio | $12 |
| Arcutis Biotherapeutics | Meals · 2025-08-06 | Zoryve | $6 |
| Genzyme | Meals · 2025-07-30 | Dupixent | $35 |
| Organon | Meals · 2025-07-23 | Vtama | $30 |
| Ucb | Meals · 2025-07-18 | Bimzelx | $16 |
| Janssen Biotech | Meals · 2025-07-17 | Tremfya | $7 |
| Genzyme | Meals · 2025-07-16 | Dupixent | $21 |
| Janssen Biotech | Meals · 2025-07-15 | Tremfya | $32 |
| Lilly USA | Meals · 2025-07-09 | Ebglyss | $28 |
| Arcutis Biotherapeutics | Meals · 2025-06-26 | Zoryve | $12 |
| Janssen Biotech | Meals · 2025-06-17 | Tremfya | $6 |
| Regeneron Healthcare Solutions | Meals · 2025-06-13 | Dupixent | $17 |
| Arcutis Biotherapeutics | Meals · 2025-06-11 | Zoryve | $3 |
| Janssen Biotech | Meals · 2025-05-27 | Tremfya | $12 |
| Arcutis Biotherapeutics | Meals · 2025-05-23 | Zoryve | $7 |
| Genzyme | Meals · 2025-05-22 | Dupixent | $14 |
| Arcutis Biotherapeutics | Meals · 2025-05-20 | Zoryve | $6 |
| Regeneron Healthcare Solutions | Meals · 2025-05-15 | Dupixent | $12 |
| Galderma Laboratories L.P. | Meals · 2025-05-15 | Nemluvio | $10 |
| Arcutis Biotherapeutics | Meals · 2025-05-13 | Zoryve | $17 |
| Abbvie | Meals · 2025-05-08 | Rinvoq | $8 |
| Janssen Biotech | Meals · 2025-05-01 | Tremfya | $11 |
| Janssen Biotech | Meals · 2025-04-30 | Tremfya | $12 |
| Abbvie | Meals · 2025-04-29 | Rinvoq | $14 |
| Lilly USA | Meals · 2025-04-28 | Ebglyss | $25 |
| Arcutis Biotherapeutics | Meals · 2025-04-28 | Zoryve | $10 |
| Lilly USA | Meals · 2025-04-23 | Taltz | $29 |
| Janssen Biotech | Meals · 2025-04-22 | Tremfya | $2 |
| Janssen Biotech | Meals · 2025-04-22 | Tremfya | $8 |
| Janssen Biotech | Meals · 2025-04-22 | Tremfya | $1 |
| MIMEDX Group | Meals · 2025-04-22 | None | $29 |
| Janssen Biotech | Meals · 2025-04-21 | Tremfya | $1 |
| Regeneron Healthcare Solutions | Meals · 2025-04-17 | Dupixent | $12 |
| Arcutis Biotherapeutics | Meals · 2025-04-17 | Zoryve | $9 |
| Abbvie | Meals · 2025-04-15 | Skyrizi | $26 |
| Genzyme | Meals · 2025-04-01 | Dupixent | $12 |
| Genzyme | Meals · 2025-04-01 | Dupixent | $10 |
| Janssen Biotech | Meals · 2025-03-31 | Tremfya | $9 |
| Abbvie | Meals · 2025-03-31 | Rinvoq | $3 |
| Galderma Laboratories L.P. | Meals · 2025-03-31 | Nemluvio | $34 |
| Regeneron Healthcare Solutions | Meals · 2025-03-25 | Dupixent | $105 |
| Abbvie | Meals · 2025-03-21 | Skyrizi | $10 |
| Abbvie | Meals · 2025-03-21 | Skyrizi | $6 |
| Abbvie | Meals · 2025-03-18 | Rinvoq | $6 |
| Incyte | Meals · 2025-03-18 | Opzelura | $18 |
| Arcutis Biotherapeutics | Meals · 2025-03-18 | Zoryve | $29 |
| Lilly USA | Meals · 2025-03-11 | Ebglyss | $18 |
| Janssen Biotech | Meals · 2025-03-10 | Tremfya | $26 |
| Lilly USA | Meals · 2025-03-05 | Taltz | $23 |
| Abbvie | Meals · 2025-03-05 | Skyrizi | $6 |
| Janssen Biotech | Meals · 2025-02-27 | Tremfya | $7 |
| Genzyme | Meals · 2025-02-27 | Dupixent | $44 |
| Ucb | Meals · 2025-02-21 | Bimzelx | $23 |
| Lilly USA | Meals · 2025-02-20 | Taltz | $22 |
| Regeneron Healthcare Solutions | Meals · 2025-02-20 | Dupixent | $16 |
| Lilly USA | Meals · 2025-02-19 | Taltz | $0 |
| Incyte | Meals · 2025-02-18 | Opzelura | $1 |
| Incyte | Meals · 2025-02-16 | Opzelura | $5 |
| Janssen Biotech | Meals · 2025-02-12 | Tremfya | $8 |
| Lilly USA | Meals · 2025-01-28 | Taltz | $12 |
| Regeneron Healthcare Solutions | Meals · 2025-01-23 | Dupixent | $37 |
| Arcutis Biotherapeutics | Meals · 2025-01-17 | Zoryve | $9 |
| Janssen Biotech | Meals · 2025-01-15 | Tremfya | $5 |
| Lilly USA | Meals · 2025-01-10 | Taltz | $24 |
| Incyte | Meals · 2025-01-09 | Opzelura | $17 |
| Galderma Laboratories L.P. | Meals · 2025-01-09 | Nemluvio | $5 |
| Galderma Laboratories L.P. | Meals · 2025-01-09 | Nemluvio | $4 |
| Galderma Laboratories L.P. | Meals · 2025-01-09 | None | $132 |
| Lilly USA | Meals · 2025-01-03 | Taltz | $5 |
| Lilly USA | Meals · 2025-01-03 | Taltz | $13 |
See earlier years (2024, 2023)
2024: $1,080
| Janssen Biotech | Tremfya | $221 | 16 payments
|
| Abbvie | Skyrizi | $203 | 14 payments
|
| Incyte | Opzelura | $154 | 11 payments
|
| Lilly USA | Taltz | $152 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $108 | 4 payments
|
| Genzyme | Dupixent | $82 | 2 payments
|
| Ucb | Bimzelx | $76 | 3 payments
|
| Regeneron Healthcare Solutions | Libtayo | $38 | 1 payment
|
| Arcutis Biotherapeutics | Zoryve | $24 | 1 payment
|
| Amgen | Otezla | $22 | 1 payment
|
2023: $56
| Lilly USA | Mounjaro | $28 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $28 | 1 payment
|
Professional record
- NPI
- 1346530029
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 1715 De Marietta Ave, Apt. 3, San Jose, CA, 95126
- NPI first listed
- 2011-04-14
- NPI last updated
- 2011-04-14
This is when the NPI record was last certified, not a medical board exam.